Glycemic Outcomes of Second-Line Diabetes Drug Choice in a Real-World Population

Hypoglycemia and acute metabolic complications (AMCs; ketoacidosis, hyperosmolarity, and coma) are glycemic outcomes that have high cost and high morbidity; these outcomes must be taken into consideration when choosing initial second-line therapy after metformin. We conducted a retrospective cohort...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Mayo Clin Proc Innov Qual Outcomes
Asıl Yazarlar: Wallia, Amisha, O’Brien, Matthew J., Liss, David T., Kang, Raymond H., Cooper, Andrew J., Gilmer, Amy, Ackermann, Ronald T.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Elsevier 2021
Konular:
Case Report
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8240148/
https://ncbi.nlm.nih.gov/pubmed/34195559
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.mayocpiqo.2021.02.008
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller